Vanderbilt University Medical Center

Displaying 11 - 19 of 19


Initiative seeks to address malnutrition among adult patients

It is estimated that nearly one out of five pediatric patients and one of three adult patients age 60 and older are malnourished and will experience a decline in their nutritional status during their hospital stay.


Study seeks to boost breast tumor immune response

Immunotherapy, which harnesses the power of the immune system, is one of the most promising forms of cancer therapy and has been shown to work well against some types of cancer. But in early studies, breast cancer has proven to be largely resistant to immunotherapies, which are effective in only about 5 to 10 percent of patients whose tumors have spread or metastasized.


A cataract-heart connection

If you’ve kept up with science-related news lately, then you’ve probably heard about CRISPR-Cas9, the latest and greatest new tool for gene editing.


Study tracks sodium-potassium pathway

A six-member group of biomedical scientists from Europe and the United States, including Eric Delpire, PhD, MS, professor of Anesthesiology, has been awarded a $6 million grant to study the role of dietary potassium in hypertension.

The five-year grant was awarded by the Paris-based Fondation LeDucq as part of its Transatlantic Networks of Excellence Program.


VUMC joins national effort to block global pandemics of potentially lethal viruses

The U.S. Defense Advanced Research Projects Agency (DARPA) has signed a five-year cooperative agreement worth up to $28 million with Vanderbilt University Medical Center (VUMC) to develop methods for preventing the global spread of viruses like chikungunya and Zika.


Study finds higher death rates in poor neighborhoods

Living in an economically disadvantaged neighborhood is likely to lead to death at an earlier age, especially among African-Americans, new research shows. The death rate is even more pronounced among disadvantaged individuals with unhealthy lifestyle habits.

A new study led by Vanderbilt-Ingram Cancer Center (VICC) investigators found that low-income residents in those socioeconomically disadvantaged neighborhoods died much earlier than the average American.


VICC, Tempus launch new data initiative to help cancer patients

Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, and Vanderbilt-Ingram Cancer Center (VICC) have announced a new collaboration to improve outcomes for cancer patients.

As part of the initial research project, Tempus will use its Tempus O platform to collect and structure clinical data from the cancer center’s electronic health record. Tempus also will provide next generation sequencing and analysis for a subset of patients in order to identify actionable gene alterations.